Paper Title
A Review on Post Approval Drug Safety Surveilliance
Article Identifiers
Authors
Prof. Shital G. Dhanmane , Ms.Pallavi. D.Hudekar , Ms.Mayuri.V.Chavan , Ms.Madhuri.D. Morey , Ms.NIkita .S. Lavhale
Keywords
Key Words: Drug Safety, Adverse Drug Reaction, Post-Marketing Surveillance, Spontaneous Reporting.
Abstract
A Review on Post Approval Drug Safety Surveilliance Dhanmane S. G*, Hudekar P. D, Chavan M.V, Morey M. D, Lavhale N.S. shital27489@gmail.com, pallavihudekar97@gmail.com, mayurichavan270@gmail.com moreymadhuri832@gmail.com, nikitalavhale1785@gmail.com Abstract Drug safety surveillance following the drug-approval process, concerns remain regarding the safety of new drugs that are introduced into the marketplace. In the case of rare adverse events, the number of subjects that are treated in randomized controlled trials is invariably inadequate to determine the safety of the new pharmaceutical. Identifying safety signals for new and/or existing drugs is a major priority in the protection of public health. Unfortunately, design, analysis, and available data are often quite limited for detecting in a timely fashion any potentially harmful effects of drugs. In this review, we examine a variety of approaches for determining the possibility of adverse drug reactions. Our review includes spontaneous reports, meta-analysis of randomized controlled clinical trials, ecological studies, and analysis of medical claims data. We consider both experimental design and analytic problems as well as potential solutions. Many of these methodologies are then illustrated. This guide proposes the development of a national post-marketing surveillance program that consists of a series of medicines quality sampling and testing activities each with an objective dictated by a country’s specific needs. Each sampling and testing activity is established with its own yearly plan developed in consultation with relevant stakeholders. Post-marketing surveillance and the associated sampling and testing activities should be coordinated and owned by the NRA and designed to address predefined objectives. The national post-marketing surveillance program should be reviewed, updated, and revised yearly.
Downloads
How To Cite (APA)
Prof. Shital G. Dhanmane , Ms.Pallavi. D.Hudekar, Ms.Mayuri.V.Chavan , Ms.Madhuri.D. Morey , & Ms.NIkita .S. Lavhale (July-2022). A Review on Post Approval Drug Safety Surveilliance. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 7(7), 582-606. https://ijnrd.org/papers/IJNRD2207072.pdf
Issue
Volume 7 Issue 7, July-2022
Pages : 582-606
Other Publication Details
Paper Reg. ID: IJNRD_181970
Published Paper Id: IJNRD2207072
Downloads: 000121971
Research Area: Pharmacy
Country: Buldana, Maharashtra, India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2207072.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2207072
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Licence
This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.
Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: September 2025
Current Issue: Volume 10 | Issue 9 | September 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 30-Sep-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
